BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22915034)

  • 1. Reduced ocular blood flow as an early indicator of diabetic retinopathy in a mouse model of diabetes.
    Muir ER; Rentería RC; Duong TQ
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6488-94. PubMed ID: 22915034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ins2Akita mouse as a model of early retinal complications in diabetes.
    Barber AJ; Antonetti DA; Kern TS; Reiter CE; Soans RS; Krady JK; Levison SW; Gardner TW; Bronson SK
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2210-8. PubMed ID: 15914643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of clinical correlates of diabetic retinopathy in the Ins2Akita retina.
    McLenachan S; Chen X; McMenamin PG; Rakoczy EP
    Clin Exp Ophthalmol; 2013 Aug; 41(6):582-92. PubMed ID: 23433122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal blood flow abnormalities following six months of hyperglycemia in the Ins2(Akita) mouse.
    Wright WS; Yadav AS; McElhatten RM; Harris NR
    Exp Eye Res; 2012 May; 98(1):9-15. PubMed ID: 22440813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal angiogenesis in the Ins2(Akita) mouse model of diabetic retinopathy.
    Han Z; Guo J; Conley SM; Naash MI
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):574-84. PubMed ID: 23221078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial frequency threshold and contrast sensitivity of an optomotor behavior are impaired in the Ins2Akita mouse model of diabetes.
    Akimov NP; Rentería RC
    Behav Brain Res; 2012 Jan; 226(2):601-5. PubMed ID: 21963766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term lutein administration attenuates retinal inflammation and functional deficits in early diabetic retinopathy using the Ins2
    Wang W; Tam KC; Ng TC; Goit RK; Chan KLS; Lo ACY
    BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32665315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of trophic factors contributes to diabetic retinopathy in the Ins2
    Araújo RS; Silva MS; Santos DF; Silva GA
    Exp Eye Res; 2020 May; 194():108027. PubMed ID: 32259534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss-of-function mutation of serine racemase attenuates retinal ganglion cell loss in diabetic mice.
    Jiang H; Du J; Song J; Li Y; Wu M; Zhou J; Wu S
    Exp Eye Res; 2018 Oct; 175():90-97. PubMed ID: 29913163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
    Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
    Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal O-linked N-acetylglucosamine protein modifications: implications for postnatal retinal vascularization and the pathogenesis of diabetic retinopathy.
    Gurel Z; Sieg KM; Shallow KD; Sorenson CM; Sheibani N
    Mol Vis; 2013; 19():1047-59. PubMed ID: 23734074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonising Wnt/β-catenin signalling ameliorates lens-capsulotomy-induced retinal degeneration in a mouse model of diabetes.
    Hombrebueno JR; Ali IHA; Ma JX; Chen M; Xu H
    Diabetologia; 2018 Nov; 61(11):2433-2446. PubMed ID: 30019207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained intraocular vascular endothelial growth factor neutralisation does not affect retinal and choroidal vasculature in Ins2
    Lechner J; Hombrebueno JR; Pedrini E; Chen M; Xu H
    Diab Vasc Dis Res; 2019 Sep; 16(5):440-449. PubMed ID: 31023085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of scotopic contrast sensitivity in the optomotor response of diabetic mice.
    Umino Y; Solessio E
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1536-43. PubMed ID: 23287790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiography reveals novel features of the retinal vasculature in healthy and diabetic mice.
    McLenachan S; Magno AL; Ramos D; Catita J; McMenamin PG; Chen FK; Rakoczy EP; Ruberte J
    Exp Eye Res; 2015 Sep; 138():6-21. PubMed ID: 26122048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of microvascular retinal changes in type I diabetic mice with optical coherence tomography angiography.
    Uehara H; Lesuma T; Stocking P; Jensen N; Kumar SR; Zhang MA; Choi S; Zhang X; Archer B; Carroll L; Ambati BK
    Exp Eye Res; 2019 Jan; 178():91-98. PubMed ID: 30268699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of endotoxin-mediated retinal inflammation on phenotype of diabetic retinopathy in Ins2 Akita mice.
    Vagaja NN; Binz N; McLenachan S; Rakoczy EP; McMenamin PG
    Br J Ophthalmol; 2013 Oct; 97(10):1343-50. PubMed ID: 23913246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose stem cells and their paracrine factors are therapeutic for early retinal complications of diabetes in the Ins2
    Elshaer SL; Evans W; Pentecost M; Lenin R; Periasamy R; Jha KA; Alli S; Gentry J; Thomas SM; Sohl N; Gangaraju R
    Stem Cell Res Ther; 2018 Nov; 9(1):322. PubMed ID: 30463601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel diabetic mouse models as tools for investigating diabetic retinopathy.
    Kador PF; Zhang P; Makita J; Zhang Z; Guo C; Randazzo J; Kawada H; Haider N; Blessing K
    PLoS One; 2012; 7(12):e49422. PubMed ID: 23251343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging indicates decreased choroidal and retinal blood flow in the DBA/2J mouse model of glaucoma.
    Lavery WJ; Muir ER; Kiel JW; Duong TQ
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):560-4. PubMed ID: 22205612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.